4.6 Article

Tgf-β1 produced by activated CD4+ T Cells Antagonizes T Cell Surveillance of Tumor Development

Journal

ONCOIMMUNOLOGY
Volume 1, Issue 2, Pages 162-171

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/onci.1.2.18481

Keywords

TGF beta; T cell tolerance; immunosurveillance; tumor immunity; immunotherapy

Funding

  1. American Cancer Society
  2. CRI predoctoral fellowship

Ask authors/readers for more resources

TGF beta 1 is a regulatory cytokine with a crucial function in the control of T cell tolerance to tumors. Our recent study revealed that T cell-produced TGF beta 1 is essential for inhibiting cytotoxic T cell responses to tumors. However, the exact TGF beta 1-producing T cell subset required for tumor immune evasion remains unknown. Here we showed that deletion of TGF beta 1 from CD8(+) T cells or Foxp3(+) regulatory T (Treg) cells did not protect mice against transplanted tumors. However, absence of TGF beta 1 produced by activated CD4(+) T cells and Treg cells inhibited tumor growth, and protected mice from spontaneous prostate cancer. These findings suggest that TGF beta 1 produced by activated CD4(+) T cells is a necessary requirement for tumor evasion from immunosurveillance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available